UNSPSC 51111624: Ancitabine

This classification denotes a pyrimidine antagonist with the molecular formula C9H11N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DO2D32W0VC, chemically known as 2,2-o-cyclocytidine but generally known as ancitabine, which bears US NIH Compound Identifier 25051. Ancitabine most often comes in base and hydrochloride forms. European Medicines Agency schedules Ancitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05507MIG.

I cannot write a summary for UNSPSC 51111624 Ancitabine based on the source provided. The source contains only the code name and number with no information about recent state and local procurement activity, issuing bodies, geographic scope, or representative opportunities under this Commodity code. Without the <most-recent-state-local-contract-opportunities> block populated with actual solicitation data, I cannot ground a business development summary in concrete procurement facts.

To produce a usable summary, I would need recent RFP, RFQ, IFB, or ITB notices naming ancitabine purchases by state agencies, counties, municipalities, school districts, transit authorities, or other state or local public bodies, along with issuing body names, notice types, response dates, and geographic locations where activity has been solicited.